Literature DB >> 9892418

Differential immunolocalization of VEGF in rat and human adult lung, and in experimental rat lung fibrosis: light, fluorescence, and electron microscopy.

H Fehrenbach1, M Kasper, M Haase, D Schuh, M Müller.   

Abstract

Vascular endothelial growth factor (VEGF) is a cytokine with main angiogenetic functions in embryonic development and tumor-formation. In the adult lung, reports of the localization of VEGF were controversial. A precise cell typing of VEGF-positive pulmonary cells is still lacking. Nothing is known about a potential role in pulmonary fibrosis. Immunohistochemistry (IH), double immunofluorescence microscopy (DIF), and immunoelectron microscopy (IEM) were used to study the differential distribution of VEGF in paraffin-embedded (IH, DIF) and in cryo-substituted, Lowicryl-embedded (IEM) specimens of normal rat and human lungs and fibrotic rat lungs. Fibrosis was induced by intratracheal bleomycin treatment. IH and DIF showed that VEGF was present in surfactant protein (SP) D-positive alveolar type II pneumocytes, bronchiolar Clara cells, smooth muscle (SM) cells, and alpha-SM actin-positive myofibroblasts of normal rat and human lungs. Fibrotic lesions in bleomycin-treated rat lungs were rich in VEGF-positive cells presenting with a heterogeneous phenotype (mainly SP-D-positive type II pneumocytes, alpha-SM actin-positive myofibroblasts). There were no signs of angiogenesis. Post-embedding immunogold labeling using protein A-gold and IgG-gold technique revealed a specific localization of VEGF to mitochondria, Clara cell secretory granules, and capillary interendothelial cell junctions. The predominant localization of VEGF to bronchiolar and alveolar epithelial and alpha-SM actin-positive cells, and the marked increase of VEGF-positive type II pneumocytes and myofibroblasts in fibrotic lung lesions, indicate that in adult lungs VEGF is involved in processes other than angiogenesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9892418     DOI: 10.1002/(SICI)1097-0185(19990101)254:1<61::AID-AR8>3.0.CO;2-D

Source DB:  PubMed          Journal:  Anat Rec        ISSN: 0003-276X


  22 in total

1.  Reactive oxygen species-mediated p38 MAPK regulates carbon nanotube-induced fibrogenic and angiogenic responses.

Authors:  Neelam Azad; Anand Krishnan V Iyer; Liying Wang; Yuxin Liu; Yongju Lu; Yon Rojanasakul
Journal:  Nanotoxicology       Date:  2012-01-20       Impact factor: 5.913

Review 2.  The mitochondrial component of intracrine action.

Authors:  Richard N Re; Julia L Cook
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-07-09       Impact factor: 4.733

3.  IL-13 stimulates vascular endothelial cell growth factor and protects against hyperoxic acute lung injury.

Authors:  J Corne; G Chupp; C G Lee; R J Homer; Z Zhu; Q Chen; B Ma; Y Du; F Roux; J McArdle; A B Waxman; J A Elias
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

4.  Sublytic membrane-attack-complex (MAC) activation alters regulated rather than constitutive vascular endothelial growth factor (VEGF) secretion in retinal pigment epithelium monolayers.

Authors:  Kannan Kunchithapautham; Bärbel Rohrer
Journal:  J Biol Chem       Date:  2011-05-12       Impact factor: 5.157

5.  Interleukin-13 and interleukin-4 induce vascular endothelial growth factor release from airway smooth muscle cells: role of vascular endothelial growth factor genotype.

Authors:  Débora S Faffe; Lesley Flynt; Kerri Bourgeois; Reynold A Panettieri; Stephanie A Shore
Journal:  Am J Respir Cell Mol Biol       Date:  2005-10-06       Impact factor: 6.914

6.  Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease.

Authors:  A R Kranenburg; W I de Boer; V K T Alagappan; P J Sterk; H S Sharma
Journal:  Thorax       Date:  2005-02       Impact factor: 9.139

7.  Nitric oxide mediates bleomycin-induced angiogenesis and pulmonary fibrosis via regulation of VEGF.

Authors:  Anand Krishnan V Iyer; Vani Ramesh; Carlos A Castro; Vivek Kaushik; Yogesh M Kulkarni; Clayton A Wright; Rajkumar Venkatadri; Yon Rojanasakul; Neelam Azad
Journal:  J Cell Biochem       Date:  2015-11       Impact factor: 4.429

8.  An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors.

Authors:  Grace Pinhal-Enfield; Madhuri Ramanathan; Gyorgy Hasko; Stefanie N Vogel; Andrew L Salzman; Geert-Jan Boons; S Joseph Leibovich
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

9.  Angiogenic cytokines in patients with idiopathic interstitial pneumonia.

Authors:  N R Simler; P E Brenchley; A W Horrocks; S M Greaves; P S Hasleton; J J Egan
Journal:  Thorax       Date:  2004-07       Impact factor: 9.139

10.  Synergistic up-regulation of vascular endothelial growth factor expression in murine macrophages by adenosine A(2A) receptor agonists and endotoxin.

Authors:  Samuel Joseph Leibovich; Jiang-Fan Chen; Grace Pinhal-Enfield; Paula C Belem; Genie Elson; Anthony Rosania; Madhuri Ramanathan; Carmen Montesinos; Marlene Jacobson; Michael A Schwarzschild; J Stephen Fink; Bruce Cronstein
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.